Nonpharmacologic interventions are commonly used as first-line treatment of ocular allergy and include avoidance, cold compresses, lubrication, and the use of disposable daily contact lenses. Pharmacologic management of ocular allergy has increased exponentially over the past decade. Clinically available agents are being expanded to specifically address the various signs and symptoms of inflammation associated with ocular allergy. Immunotherapy has been shown to decrease the sensitivity of the eye 10 to 100 fold and may have an effect for several years after halting of immunotherapy.